Evidence map›Paper›PMID 28733581›Full record

ArticleScientific reports2017

Structural determinants at the M2 muscarinic receptor modulate the RGS4-GIRK response to pilocarpine by impairment of the receptor voltage sensitivity.

I-Shan Chen, Kazuharu Furutani, Yoshihisa Kurachi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. The association between RGS4 and choline in cardiac fibrosis.Cell communication and signaling : CCS · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

I-Shan ChenDepartment of Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan.
Kazuharu FurutaniDepartment of Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan. furutani@pharma2.med.osaka-u.ac.jp.
Yoshihisa KurachiDepartment of Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan. ykurachi@pharma2.med.osaka-u.ac.jp.
Osaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Membrane potential controls the response of the M2 muscarinic receptor to its ligands. Membrane hyperpolarization increases response to the full agonist acetylcholine (ACh) while decreasing response to the partial agonist pilocarpine. We previously have demonstrated that the regulator of G-protein signaling (RGS) 4 protein discriminates between the voltage-dependent responses of ACh and pilocarpine; however, the underlying mechanism remains unclear. Here we show that RGS4 is involved in the voltage-dependent behavior of the M2 muscarinic receptor-mediated signaling in response to pilocarpine. Additionally we revealed structural determinants on the M2 muscarinic receptor underlying the voltage-dependent response. By electrophysiological recording in Xenopus oocytes expressing M2 muscarinic receptor and G-protein-gated inwardly rectifying K

Indexed as

Amino Acid MotifsAmino Acid SequenceAnimalsG Protein-Coupled Inwardly-Rectifying Potassium ChannelsIon Channel GatingModels, MolecularMuscarinic AgonistsMutationOocytesPilocarpineRatsReceptor, Muscarinic M2RGS ProteinsSignal TransductionStructure-Activity RelationshipXenopus laevisG Protein-Coupled Inwardly-Rectifying Potassium ChannelsMuscarinic AgonistsPilocarpineReceptor, Muscarinic M2RGS4 proteinRGS Proteins

Identifiers

PMID28733581
PMCPMC5522400
OpenAlexW2734976023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.